Elanco Animal Health INC Form 4 insider transactions

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on February 7, 2025.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired deferred stock units representing the right to receive common stock or cash equivalent, according to a recent SEC filing.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, reported the acquisition of deferred stock units on January 24, 2025.

Rajeev A. Modi, an executive at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash.

Elanco Animal Health's CEO, Jeffrey N. Simmons, reported the acquisition of deferred stock units convertible to common stock, according to a Form 4 filing with the SEC.

James M. Meer, Chief Accounting Officer of Elanco Animal Health, disposed of 414 shares of common stock on January 3, 2025.

Grace McArdle, EVP of Manufacturing and Quality at Elanco Animal Health, disposed of 351 shares of common stock on January 3, 2025.

Director Lawrence Kurzius reports acquisition of deferred stock units in Elanco Animal Health Inc. through a director deferral plan.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 229.6219 deferred stock units on December 27, 2024, convertible to common stock or cash.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 228.8628 deferred stock units on December 13, 2024, which will convert to common stock or cash upon termination or at a future date.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired deferred stock units representing the right to receive common stock or cash.

Director Kirk McDonald of Elanco Animal Health Inc. received 18,169 deferred stock units as part of an annual equity award.

Elanco Animal Health director Lawrence Kurzius received 18,169 shares of common stock as part of an annual equity award.

Elanco Animal Health director Deborah Kochevar received 18,169 shares of common stock as part of an annual equity award.

Elanco Animal Health director Michael J. Harrington received 18,169 shares of common stock as part of an annual equity award.

Elanco Animal Health director Paul Herendeen received 18,169 shares of common stock as part of an annual equity award.

Elanco Animal Health director Art A. Garcia received 18,169 deferred stock units as part of an annual equity award.

Director William F. Doyle of Elanco Animal Health Inc. received 18,169 shares of common stock as part of an annual equity award.

Director Kapila K. Anand of Elanco Animal Health Inc. received 18,169 shares of common stock as part of an annual equity award.

Denise Scots-Knight, a director at Elanco Animal Health, received 18,169 shares of common stock as part of an annual equity award.

Elanco Animal Health director John P. Bilbrey received a grant of 18,169 deferred stock units and disposed of 78,400 common shares held in a revocable trust.

R. David Hoover, a director at Elanco Animal Health, reported the acquisition of 18,169 shares of common stock and the disposal of 185,000 shares held in a revocable trust.

Stacey Ma, a director at Elanco Animal Health, received 2,539 shares of common stock as part of an annual equity award.

Director Kathy V. Turner of Elanco Animal Health Inc. received 13,838 shares of common stock as part of an annual equity award.

Craig S. Wallace, a director at Elanco Animal Health, acquired 13,838 shares of common stock through a grant of deferred stock units.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired 104,816 deferred stock units on November 29, 2024.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 209.6321 deferred stock units, convertible to common stock, on November 29, 2024.

Elanco Animal Health's CEO, Jeffrey N. Simmons, acquired 198.0858 deferred stock units, convertible to common stock, on November 15, 2024.

Rajeev A. Modi, an Executive Vice President at Elanco Animal Health, acquired 99.0429 deferred stock units on November 15, 2024.